Conference
REACH-3 trial design: A Phase 3, Randomized Study to Assess Ruxolitinib over BAT in Patients with Corticosteroid-Refractory Chronic Graft-versus-Host Disease Post Allo-HSCT
Authors
Zeiser R; Ram R; Foley SR; Yeshurun M; Locatelli F; Gadbaw B; Atienza E; Hollaender N; Teshima T
Volume
53
Pagination
pp. 444-446
Publisher
NATURE PUBLISHING GROUP
Publication Date
September 1, 2018
Name of conference
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)
Conference place
Lisbon, PORTUGAL
Conference start date
March 18, 2018
Conference end date
March 21, 2018
Conference proceedings
BONE MARROW TRANSPLANTATION
ISSN
0268-3369